Related Experiment Video
Updated: Jun 17, 2026

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure
Published on: November 29, 2018
Mechanisms of respiratory insufficiency induced by methadone overdose in rats
Lucie Chevillard1, Bruno Mégarbane, Frédéric J Baud
1Université Paris-Descartes, Faculté de Pharmacie, Neuropsychopharmacologie des addictions, CNRS, UMR 7157, Paris, France.
Abstract:
Methadone may cause respiratory depression. We aimed to understand methadone-related effects on ventilation as well as each opioid-receptor (OR) role. We studied the respiratory effects of intraperitoneal methadone at 1.5, 5, and 15 mg/kg (corresponding to 80% of the lethal dose-50%) in rats using arterial blood gases and plethysmography. OR antagonists, including intravenous 10 mg/kg-naloxonazine at 5 minutes (mu-OR antagonist), subcutaneous 30 mg/kg-naloxonazine at 24 hours (micro1-OR antagonist), 3 mg/kg-naltrindole at 45 minutes (delta-OR antagonist) and 5 mg/kg-Nor-binaltorphimine at 6 hours (kappa-OR antagonist) were pre-administered. Plasma concentrations of methadone enantiomers were measured using high-performance liquid chromatography coupled to mass-spectrometry. Methadone dose-dependent inspiratory time (T(I)) increase tended to be linear. Respiratory depression was observed only at 15 mg/kg and characterized by an increase in expiratory time (T(E)) resulting in hypoxemia and respiratory acidosis. Intravenous naloxonazine completely reversed all methadone-related effects on ventilation, while subcutaneous naloxonazine reduced its effects on pH (P < 0.05), PaCO(2) (P < 0.01) and T(E) (P < 0.001) but only partially on T(I) (P < 0.001). Naltrindole reduced methadone-related effects on T(E) (P < 0.001). Nor-binaltorphimine increased methadone-related effects on pH and PaO(2) (P < 0.05) Respiratory effects as a function of plasma R-methadone concentrations showed a decrease in PaO(2) (EC(50): 1.14 microg/ml) at lower concentrations than those necessary for PaCO(2) increase (EC(50): 3.35 microg/ml). Similarly, increased T(I) (EC(50): 0.501 microg/ml) was obtained at lower concentrations than those for T(E) (EC(50): 4.83 microg/ml). Methadone-induced hypoxemia is caused by mu-ORs and modulated by kappa-ORs. Additionally, methadone-induced increase in T(E) is caused by mu1- and delta-opioid receptors while increase in T(I) is caused by mu-ORs.
Insights
Methadone causes respiratory depression by increasing inspiratory time and decreasing expiratory time, primarily through mu-opioid receptors. Kappa-opioid receptors modulate hypoxemia, while mu1- and delta-opioid receptors influence expiratory time.
Area of Science:
- Pharmacology
- Respiratory Physiology
- Neuroscience
Background:
- Methadone is an opioid analgesic used for pain management and opioid use disorder treatment.
- Opioid medications, including methadone, are known to cause respiratory depression.
- The specific roles of different opioid receptors (ORs) in mediating methadone's respiratory effects are not fully elucidated.
Purpose of the Study:
- To investigate the dose-dependent respiratory effects of methadone in rats.
- To determine the involvement of specific opioid receptors (mu-OR, mu1-OR, delta-OR, kappa-OR) in methadone-induced respiratory depression.
- To correlate plasma concentrations of methadone enantiomers with respiratory parameters.
Main Methods:
- Rats were administered intraperitoneal methadone at varying doses (1.5, 5, and 15 mg/kg).
- Respiratory parameters were measured using arterial blood gases and plethysmography.
- Specific opioid receptor antagonists (naloxonazine, naltrindole, Nor-binaltorphimine) were pre-administered to assess receptor roles.
- Plasma concentrations of methadone enantiomers were quantified using LC-MS/MS.
Main Results:
- Methadone caused a dose-dependent increase in inspiratory time (T(I)).
- Significant respiratory depression, characterized by increased expiratory time (T(E)), hypoxemia, and respiratory acidosis, occurred at the highest methadone dose (15 mg/kg).
- Intravenous naloxonazine (mu-OR antagonist) completely reversed methadone's effects; other antagonists partially reversed or modulated specific effects, indicating differential receptor involvement.
Conclusions:
- Methadone-induced hypoxemia is primarily mediated by mu-opioid receptors (mu-ORs) and modulated by kappa-opioid receptors.
- Increased expiratory time (T(E)) is mediated by mu1- and delta-opioid receptors.
- Increased inspiratory time (T(I)) is mediated by mu-ORs, with dose-dependent effects observed.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

